The Food and Drug Administration approved an updated COVID-19 vaccine. The new vaccine targets the JN.1-lineage XFG variant of the virus.

The mRNA vaccines from Pfizer and BioNTech are approved for adults 65 and older and others with conditions that put them at risk for serious illness.